US20100275936A1 - Smokeless dissolvable compressed tobacco product - Google Patents

Smokeless dissolvable compressed tobacco product Download PDF

Info

Publication number
US20100275936A1
US20100275936A1 US12/695,697 US69569710A US2010275936A1 US 20100275936 A1 US20100275936 A1 US 20100275936A1 US 69569710 A US69569710 A US 69569710A US 2010275936 A1 US2010275936 A1 US 2010275936A1
Authority
US
United States
Prior art keywords
tobacco
dissolvable compressed
tobacco product
smokeless dissolvable
smokeless
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/695,697
Other languages
English (en)
Inventor
Håkan Bivehed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philip Morris USA Inc
Original Assignee
Philip Morris USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Morris USA Inc filed Critical Philip Morris USA Inc
Assigned to PHILIP MORRIS USA INC. reassignment PHILIP MORRIS USA INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BIVEHED, HAKAN
Publication of US20100275936A1 publication Critical patent/US20100275936A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/183—Treatment of tobacco products or tobacco substitutes sterilization, preservation or biological decontamination
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/20—Biochemical treatment

Definitions

  • a number of oral smokeless non-dissolvable tobacco products that include an insoluble residual component that is disposed of by a consumer after use are known in the art.
  • Known smokeless non-dissolvable tobacco products include: plug, twist, and loose leaf chewing tobacco; dry snuff; moist snuff, which typically contains finely cut fermented moist tobacco; loose or portioned snus, which typically contains finely ground moist tobacco; and tobacco-containing chewing gum.
  • a number of oral smokeless dissolvable tobacco products that dissolve in the mouth of a consumer are also known.
  • smokeless dissolvable compressed tobacco products in the form of pills, tablets and lozenges which include powdered or ground tobacco together with other ingredients.
  • Raw, unprocessed tobacco may contain increased levels of viable bacteria. As smokeless dissolvable compressed tobacco products dissolve and the tobacco in such products is ingested by the consumer, it would be desirable to provide an improved method for treating a smokeless dissolvable compressed tobacco product for oral use.
  • the present invention relates to an oral smokeless dissolvable compressed tobacco product.
  • a smokeless dissolvable compressed tobacco product includes a pasteurized tobacco component.
  • the smokeless dissolvable compressed tobacco product has a total aerobic microbial count of less than 2 log cfu/g.
  • the pasteurized tobacco component includes particulate tobacco with an average particle size ranging from about 100 nm to about 0.5 mm.
  • the smokeless dissolvable compressed tobacco product can also include one or more non-tobacco components selected from the group consisting of: acidity regulators, buffering agents, fillers, binders, gelling agents, lubricants, anti-adherents, glidants, disintegration agents, sweeteners, flavorants, taste enhancers and colorants.
  • the smokeless dissolvable compressed tobacco product includes at least one binder or filler, at least one lubricant, anti-adherent or glidant, at least one acidity regulator, at least one flavorant, and at least one sweetener.
  • the smokeless dissolvable compressed tobacco product can include one or more of a gelling agent, a taste enhancer, a colorant, and a disintegration agent.
  • a method of making a smokeless dissolvable compressed tobacco product having a total aerobic microbial count of less than 2 log cfu/g includes the steps of: pasteurizing a tobacco component so as to reduce the total aerobic microbial count thereof to less than 2 log cfu/g and the total yeast and mold count thereof to less than 2 log cfu/g; mixing the pasteurized tobacco component with one or more non-tobacco components; and compressing the pasteurized tobacco component and one or more non-tobacco components to form a smokeless dissolvable compressed tobacco product.
  • the step of pasteurizing the tobacco component includes direct heating of the tobacco by hot steam injection to a temperature ranging from about 100° C. to about 120° C.
  • the step of pasteurizing the tobacco component includes direct heating of the tobacco component by repeated hot steam injection to temperatures of at least about 100° C.
  • the method can also include the step of adjusting the pH of the pasteurized tobacco component to about 7.5 and about 8.9 prior to compressing the pasteurized tobacco component and one or more non-tobacco components to form the smokeless dissolvable compressed tobacco product.
  • FIGS. 1( a ), 1 ( b ), and 1 ( c ) show perspective, side and top views, respectively, of a first embodiment of a smokeless dissolvable compressed tobacco product
  • FIGS. 2( a ), 2 ( b ), and 2 ( c ) show perspective, side and top views, respectively, of a second embodiment of a smokeless dissolvable compressed tobacco product
  • FIGS. 3( a ), 3 ( b ), and 3 ( c ) show perspective, side and top views, respectively, of a third embodiment of a smokeless dissolvable compressed tobacco product
  • FIGS. 4( a ), 4 ( b ), and 4 ( c ) show perspective, side and top views, respectively, of a fourth embodiment of a smokeless dissolvable compressed tobacco product
  • FIGS. 5( a ), 5 ( b ), and 5 ( c ) show perspective, side and top views, respectively, of a fifth embodiment of a smokeless dissolvable compressed tobacco product
  • FIGS. 6( a ), 6 ( b ), and 6 ( c ) show perspective, side and top views, respectively, of a sixth embodiment of a smokeless dissolvable compressed tobacco product
  • FIGS. 7( a ), 7 ( b ), and 7 ( c ) show perspective, side and top views, respectively, of a seventh embodiment of a smokeless dissolvable compressed tobacco product
  • FIGS. 8( a ), 8 ( b ), and 8 ( c ) show perspective, side and top views, respectively, of an eighth embodiment of a smokeless dissolvable compressed tobacco product
  • FIGS. 9( a ), 9 ( b ), and 9 ( c ) show perspective, side and top views, respectively, of a ninth embodiment of a smokeless dissolvable compressed tobacco product
  • FIGS. 10( a ), 10 ( b ), and 10 ( c ) show perspective, side and top views, respectively, of a tenth embodiment of a smokeless dissolvable compressed tobacco product
  • FIGS. 11( a ), 11 ( b ), and 11 ( c ) show perspective, side and top views, respectively, of an eleventh embodiment of a smokeless dissolvable compressed tobacco product.
  • FIGS. 12( a ), 12 ( b ), and 12 ( c ) show perspective, side and top views, respectively, of a twelfth embodiment of a smokeless dissolvable compressed tobacco product.
  • a smokeless dissolvable compressed tobacco product includes a pasteurized tobacco component.
  • the substantially aseptic smokeless dissolvable compressed tobacco product has a total aerobic microbial count (also known as “TAMC”) of less than 2 log cfu/g, i.e., log 10 cfu/g, where cfu/g is the value of conventionally measured colony forming units per gram.
  • TAMC total aerobic microbial count
  • a method of making a smokeless dissolvable compressed tobacco product having a total aerobic microbial count of less than 2 log cfu/g includes the step of pasteurizing a tobacco component to reduce the total aerobic microbial count to less than 2 log cfu/g and the total yeast and mold count to less than 2 log cfu/g. The method also includes the steps of mixing the pasteurized tobacco component with one or more non-tobacco components, and compressing the pasteurized tobacco component and one or more non-tobacco components to form a smokeless dissolvable compressed tobacco product.
  • the total aerobic microbial count is measured in accordance with the Nordic Committee on Food Analysis (NMKL) method No 86, 4. Ed., 2006 and the total yeast and mold count specified is measured in accordance with NMKL method No 98, 4. Ed., 2005.
  • the NMKL method No 86, 4. Ed., 2006 is used to determine the aerobic plate count by preparing a dilution series of sample material according to general microbiological principles, followed by pour-plating into an agar medium in Petri dishes. In this method, the samples are incubated under aerobic conditions at either 30° C. for 3 days, 20° C. for 3 days, or 6.5° C. for 10 days. In the NMKL method No 98, 4.
  • yeast and mold count is determined by surface inoculation of appropriate dilution series on dichloran rose bengal agar (DRBC), dichloran glycerol agar (DG18) or oxytetracykline glucose yeast extract agar (OGYE) dependent on which matrix are analysed.
  • DRBC dichloran rose bengal agar
  • DG18 dichloran glycerol agar
  • OYE oxytetracykline glucose yeast extract agar
  • the tobacco component may be pasteurized using any suitable technique provided that the pasteuriation parameters such as temperature and time are sufficient to reduce the total aerobic microbial count of the tobacco component to less than 2 log cfu/g and the total yeast and mold count of the tobacco component to less than 2 log cfu/g to render the tobacco component substantially aseptic.
  • the pasteuriation parameters such as temperature and time are sufficient to reduce the total aerobic microbial count of the tobacco component to less than 2 log cfu/g and the total yeast and mold count of the tobacco component to less than 2 log cfu/g to render the tobacco component substantially aseptic.
  • Suitable pasteurization techniques include, but are not limited to, single hot steam injection, repeated hot steam injection and indirect heating.
  • the tobacco component is pasteurized by hot steam injection, more preferably by repeated hot steam injection.
  • the step of pasteurizing the tobacco component includes direct heating of the tobacco by hot steam injection to a temperature ranging from about 100° C. to about 120° C. for a period ranging from about 1 minute tod about 30 minutes. More preferably, the step of pasteurizing the tobacco component includes direct heating of the tobacco component by repeated hot steam injection to temperatures of at least about 100° C.
  • the heat treatment of the tobacco component during pasteurization advantageously results in the formation of tobacco-derived flavorings.
  • the tobacco component may be pasteurized together with water.
  • the tobacco component may be pasteurized with one or more other additives approved for use in the food industry, including, but not limited to, sodium chloride, sodium carbonate, potassium carbonate, propylene glycol, glycerol and combinations thereof.
  • the pH of the pasteurized tobacco component may be adjusted prior to compressing the pasteurized tobacco component and one or more non-tobacco components to form the smokeless dissolvable compressed tobacco product.
  • the pH of the pasteurized tobacco component is adjusted to between about 7.5 and about 8.9.
  • the pH of the pasteurized tobacco component may be adjusted through the addition of one or more acidity regulators.
  • Suitable acidity regulators approved for use in the food industry are known in the art and include, but are not limited to: alkali carbonates, such as sodium carbonate and potassium carbonate; calcium carbonate; alkali hydroxides, such as sodium hydroxide and potassium hydroxide; calcium hydroxide; magnesium hydroxide; and combinations thereof.
  • the pH of the pasteurized tobacco component is adjusted prior to mixing the pasteurized tobacco component with the one or more non-tobacco components.
  • the pH of the pasteurized tobacco component may be adjusted by mixing the pasteurized tobacco component with one or more non-tobacco components including at least one acidity regulator or buffering agent.
  • the tobacco component may include one or more of tobacco lamina, tobacco stem, expanded tobacco and reconstituted tobacco.
  • the tobacco component may include a blend of two or more different types of tobacco.
  • the tobacco component may include a blend of two or more of different types of tobacco selected from the group consisting of Virginia, Burley, Maryland, Nicotiana rustica and oriental tobacco.
  • the tobacco component may include a single type of tobacco.
  • the tobacco component may include tobacco that has been one or more of dried, aged, flue-cured, air-cured, fire-cured, sun-cured, shredded, powdered and ground.
  • the tobacco component includes air-cured tobacco, sun-cured tobacco, dark air-cured tobacco or a combination thereof.
  • the tobacco component includes particulate tobacco. More preferably, the tobacco component includes powdered tobacco, ground tobacco or a combination thereof.
  • the particulate tobacco may have any suitable average particle size.
  • the particulate tobacco may have an average particle size of less than about 1 mm, less than about 0.5 mm, or less than about 0.1 mm.
  • the particulate tobacco has an average particle size ranging from about 100 nm to about 1 mm, more preferably ranging from about 100 nm to about 0.5 mm.
  • the tobacco may be ground and sieved in a typical manner in order to obtain a desired particle size.
  • the smokeless dissolvable compressed tobacco product further includes one or more non-tobacco components.
  • smokeless dissolvable compressed tobacco products may further include one or more non-tobacco components approved for use in the food industry selected from the group consisting of: acidity regulators, buffering agents, fillers, binders, gelling agents, lubricants, anti-adherents, glidants, disintegration agents, sweeteners, flavorants, taste enhancers and colorants.
  • the tobacco component may be dry blended or otherwise mixed with the one or more non-tobacco components.
  • the tobacco component and one or more non-tobacco components may be ground together or mixed in a twisting powder mixer.
  • the tobacco component may be present in the smokeless dissolvable compressed tobacco product in an amount ranging from about 0.5% to about 60% of the dry weight of the compressed tobacco product.
  • the amount of the tobacco component may be selected as a function of, for example, the desired nicotine content or the desired flavor or other organoleptic properties of the smokeless dissolvable compressed tobacco product.
  • the smokeless dissolvable compressed tobacco product includes: at least one binder or filler; at least one lubricant, anti-adherent or glidant; at least one acidity regulator; at least one flavorant; and at least one sweetener.
  • the smokeless dissolvable compressed tobacco product also includes one or more of a gelling agent, a taste enhancer, a colorant and a disintegration agent.
  • the smokeless dissolvable compressed tobacco product includes at least one binder or filler.
  • binder and filler are used to refer to any component that increases the disintegration time of the dissolvable compressed tobacco product, maintains the integrity of the dissolvable compressed tobacco product, increases the hardness of the dissolvable compressed tobacco product, reduces the friability of the dissolvable compressed tobacco product or adds bulk to the smokeless dissolvable compressed tobacco product. It will be appreciated that a single non-tobacco component may perform the functions of a binder and a filler.
  • the smokeless dissolvable compressed tobacco product may optionally include one or more gelling agents.
  • gelling agent is used to refer to any component that affects the mouth feel of the smokeless dissolvable compressed tobacco product when dissolved in the mouth of a consumer.
  • Suitable binders, fillers and gelling agents include, but are not limited to: non-tobacco plant fibres; starches, including pre-gelatinized starch; gums, including natural gums, such as xanthan gum, gum, acacia, gum arabic, guar gum, locust bean gum and sodium alginate; pectins; gelatin; agar; carrageenan; pullulan; microcrystalline cellulose; methyl cellulose; carboxymethyl cellulose; dextrins, including maltodextrin; sugar alcohols, such as erythritol, xylitol mannitol, sorbitol, isomalt, maltitol and lactitol; glucose; lactose; sucrose; polyvidone; calcium sulfate dihydrate; and combinations thereof.
  • non-tobacco plant fibres starches, including pre-gelatinized starch
  • gums including natural gums, such as xanthan gum, gum, a
  • the smokeless dissolvable compressed tobacco product includes microcrystalline cellulose, which functions as a binder and a filler.
  • the smokeless dissolvable compressed tobacco product may optionally include one or more lubricants, anti-adherents, glidants or combinations thereof.
  • lubricant anti-adherent and glidant are used to refer to any component that facilitates manufacturing of the smokeless dissolvable compressed tobacco product by reducing friction, reducing adhesion, or otherwise improving flow properties. It will be appreciated that a single non-tobacco component may perform the functions of one or more of a lubricant, an anti-adherent and a glidant.
  • Suitable lubricants, anti-adherents and glidants include, but are not limited to: stearates, including magnesium stearate, calcium stearate, sodium stearate, zinc stearate, and derivatives thereof, including sodium stearyl fumarate; fatty acids, including stearic acid; silicates, including magnesium silicates and calcium silicates; starch; lauryl sulfates, including magnesium lauryl sulfate and sodium lauryl sulfate; polyethylene glycol; and silica aerogels, including colloidal fumed silica.
  • the one or more lubricants, anti-adherents, glidants or combinations thereof may be present in the smokeless dissolvable compressed tobacco product in an amount of, for example, between about 0.1% to about 5% of the dry weight of the compressed tobacco product.
  • the one or more lubricants, anti-adherents, glidants or combinations thereof are present in the smokeless dissolvable compressed tobacco product in an amount of less than about 1% of the dry weight of the compressed tobacco product, more preferably in an amount of about 0.2% of the dry weight of the compressed tobacco product.
  • the smokeless dissolvable compressed tobacco product may optionally include one or more disintegrants.
  • disintegrant is used to refer to any component that facilitates breakup or disintegration of the smokeless dissolvable compressed tobacco product when placed in a consumer's mouth.
  • Suitable disintegrants include, but are not limited to: starches, including pregelatinised starch; sodium starch glycolate; sodium alginate; croscarmellose sodium; crosslinked polyvinylpyrrolidone, including crospovidone; sodium carboxymethyl cellulose; calcium carboxymethyl cellulose; sodium bicarbonate; and calcium carbonate.
  • the one or more disintegrants may be present in the smokeless dissolvable compressed tobacco product in an amount, for example, ranging from about 1% to about 15% of the dry weight of the compressed tobacco product.
  • Smokeless dissolvable compressed tobacco product may optionally include one or more sweeteners.
  • Smokeless dissolvable compressed tobacco products may include natural sweeteners, artificial sweeteners or combinations thereof.
  • Suitable natural and artificial sweeteners are known in the art and include, but are not limited to: monosaccharides, such as glucose, fructose, ribose xylose and invert sugar; disaccharides, such as lactose, maltose and sucrose; sugar alcohols, such as erythritol, xylitol mannitol, sorbitol, isomalt, maltitol and lactitol; and artificial sweeteners, such as sucralose, aspartame, saccharin, acesulfame K, and cyclamate,
  • the smokeless dissolvable compressed tobacco product may optionally include one or more flavorants.
  • Smokeless dissolvable compressed tobacco products may include natural flavorants, artificial flavorants or combinations thereof.
  • the one or more flavorants may be added in encapsulated or non-encapsulated form.
  • Suitable natural and artificial flavorants include, but are not limited to, peppermint, spearmint, wintergreen, menthol, eucalyptus oil, angelica, anise, anethole, carvone, vanillin, vanilla, basil oil, cardamom, cassia, cinnamon, clove, cocoa, coriander oil, fennel oil, fenugreek, ginger, lemon grass, liquorice, nutmeg, palmarosa oil, sage oil, acacia, amber, clary, geranium, jasmine, juniper berry, lavender oil, magnolia, oak moss, orris root, osmanthus, rose oil, sandalwood, bergamot oil, lemon oil, lime oil, orange oil, fruit extracts, fruit flavoring, almond, coconut, chocolate, coffee, tea, arrack, rum, cognac, whisky, and gin.
  • the one or more flavorants may be present in the smokeless dissolvable compressed tobacco product in an amount, for example, ranging from about 0.1% to about 4% of the dry weight of the compressed tobacco product.
  • the smokeless dissolvable compressed tobacco product may optionally include one or more taste enhancers such as, for example, sodium chloride or ammonium chloride.
  • the smokeless dissolvable compressed tobacco product may optionally include one or more colorants to, for example, indicate or reflect the flavor or brand of the compressed tobacco product or otherwise enhance its aesthetic appearance.
  • smokeless dissolvable compressed tobacco products may include multifunctional non-tobacco components that perform two or more of the functions previously described above.
  • the smokeless dissolvable compressed tobacco product may include a multifunctional non-tobacco component that functions as at least two of: (i) a binder or filler; (ii) a lubricant, anti-adherent or glidant; and (iii) a disintegrant.
  • the smokeless dissolvable compressed tobacco product may include pre-gelatinised starch that functions as a binder, lubricant and disintegrant.
  • smokeless dissolvable compressed tobacco products may also include mutlifunctional non-tobacco components that perform two or more other functions.
  • the smokeless dissolvable compressed tobacco product may include a sugar alcohol that acts as a binder and a sweetener, or colloidal fumed silica that acts as a glidant and a desiccant.
  • Other suitable known desiccants such as, for example, magnesium sulfate may also be included in smokeless dissolvable compressed tobacco products to control the moisture content thereof.
  • the pasteurized tobacco component may be dry blended with one or more non-tobacco components and then directly compressed in a typical manner to form the smokeless dissolvable compressed tobacco product.
  • the pasteurized tobacco component and one or more non-tobacco components maybe be directly compressed using, for example, a tablet press having a single die and punch arrangement or a rotary tablet press having multiple dies.
  • the pasteurized tobacco component may optionally be wet granulated in a typical manner using, for example, a fluid bed granulator.
  • the compression forces used to form the smokeless dissolvable compressed tobacco product may be selected based on a number of factors. These factors include: the type of apparatus employed to compress the tobacco component and one or more non-tobacco components; the size of the smokeless dissolvable compressed tobacco product; the desired physical and mechanical properties of the smokeless dissolvable compressed tobacco product, including but not limited to the hardness, friability, disintegration or dissolution characteristics; and the desired appearance of the compressed smokeless dissolvable compressed tobacco product.
  • smokeless dissolvable compressed tobacco products may be produced having a hardness ranging from about 2 N and about 300 N.
  • smokeless dissolvable compressed tobacco products may be produced that dissolve in the mouth of an average consumer within about 5 minutes to about 45 minutes.
  • smokeless dissolvable compressed tobacco products according to the invention dissolve in the mouth of an average consumer within about 5 minutes to about 15 minutes.
  • smokeless dissolvable compressed tobacco products which dissolve in the mouth of an average consumer within about 30 minutes to about 45 minutes and which can be sucked by a consumer and then “parked” between their cheek and gum may be advantageously produced.
  • one or more surfaces of the formed smokeless dissolvable compressed tobacco product may be embossed or debossed.
  • the formed smokeless dissolvable compressed tobacco product may be at least partially coated in a typical manner using, for example, a pan coater.
  • Smokeless dissolvable compressed tobacco products may be produced in one or more predetermined shapes or configurations.
  • FIGS. 1-12 show: (a) perspective views; (b) side views; and (c) top views, respectively, of exemplary different shaped smokeless dissolvable compressed tobacco products.
  • the smokeless dissolvable compressed tobacco product can have a generally oblong shape with substantially flat or planar faces.
  • the smokeless dissolvable compressed tobacco product can have a generally disk shaped configuration with substantially flat or planar faces.
  • FIGS. 1-12 show: (a) perspective views; (b) side views; and (c) top views, respectively, of exemplary different shaped smokeless dissolvable compressed tobacco products.
  • the smokeless dissolvable compressed tobacco product can have a generally oblong shape with substantially flat or planar faces.
  • the smokeless dissolvable compressed tobacco product can have a generally disk shaped configuration with substantially flat or planar faces.
  • FIGS. 1-12 show: (a) perspective views; (b) side views; and (c) top views
  • the smokeless dissolvable compressed tobacco product can have a generally disk shaped configuration with domed or convex faces.
  • the smokeless dissolvable compressed tobacco product can have a generally spherical shape.
  • the smokeless dissolvable compressed tobacco product can have a generally oblong shape with domed or convex faces. As shown in FIGS.
  • the smokeless dissolvable compressed tobacco product can have an oblong shape with biaxially symmetric faces.
  • the smokeless dissolvable compressed tobacco product can have an elongated generally rectangular parallelepiped shape.
  • the smokeless dissolvable compressed tobacco product can have a generally rectangular parallelepiped shape.
  • the smokeless dissolvable compressed tobacco product can have a generally square opposed surfaces. As shown in FIGS.
  • the smokeless dissolvable compressed tobacco product can have a generally pyramidal structure. As shown in FIGS. 11( a ), 11 ( b ), and 11 ( c ), the smokeless dissolvable compressed tobacco product can have generally triangular opposed surfaces. As shown in FIGS. 12( a ), 12 ( b ), and 12 ( c ), the smokeless dissolvable compressed tobacco product can have generally hexagonal opposed surfaces.
  • Smokeless dissolvable compressed tobacco products may also be produced in a variety of different sizes.
  • smokeless dissolvable compressed tobacco products may have a diameter ranging from about 2 mm to about 30 mm and a weight ranging from about 0.1 g to about 3.0 g.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Manufacture Of Tobacco Products (AREA)
US12/695,697 2009-01-28 2010-01-28 Smokeless dissolvable compressed tobacco product Abandoned US20100275936A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09250218.6 2009-01-28
EP09250218A EP2213181A1 (en) 2009-01-28 2009-01-28 Smokeless dissolvable compressed tobacco product

Publications (1)

Publication Number Publication Date
US20100275936A1 true US20100275936A1 (en) 2010-11-04

Family

ID=40983458

Family Applications (1)

Application Number Title Priority Date Filing Date
US12/695,697 Abandoned US20100275936A1 (en) 2009-01-28 2010-01-28 Smokeless dissolvable compressed tobacco product

Country Status (15)

Country Link
US (1) US20100275936A1 (da)
EP (2) EP2213181A1 (da)
JP (1) JP2012516137A (da)
KR (1) KR101779615B1 (da)
BR (1) BRPI0924206A2 (da)
CA (1) CA2737323C (da)
DK (1) DK2381803T3 (da)
EC (1) ECSP11011291A (da)
MX (1) MX2011003882A (da)
MY (1) MY159762A (da)
PL (1) PL2381803T3 (da)
RU (1) RU2011115844A (da)
TW (1) TWI513413B (da)
UA (1) UA100473C2 (da)
WO (1) WO2010086010A1 (da)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012074865A1 (en) * 2010-12-01 2012-06-07 R. J. Reynolds Tobacco Company Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products
WO2012075035A3 (en) * 2010-12-01 2012-07-26 R. J. Reynolds Tobacco Company Smokeless tobacco pastille and moulding process for forming smokeless tobacco products
US20130340776A1 (en) * 2012-06-20 2013-12-26 Munmaya K. Mishra Smokeless Tobacco Lipid Granules
US20140020692A1 (en) * 2011-03-30 2014-01-23 Japan Tobacco Inc. Oral tobacco and method for manufacturing the same
US20150096574A1 (en) * 2013-10-03 2015-04-09 Altria Client Services Inc. Dissolvable-chewable tobacco tablet
USD735054S1 (en) * 2007-11-15 2015-07-28 Swedish Match North Europe Ab Snuff box with snuff bags
USD744160S1 (en) * 2005-10-18 2015-11-24 Swedish Match North Europe Ab Snuff box
US20190246685A1 (en) * 2013-03-14 2019-08-15 Altria Client Services Llc Smokeless tobacco article
US20200054064A1 (en) * 2017-05-24 2020-02-20 Philip Morris Products S.A. Heated aerosol-generating article comprising homogenised botanical material

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2587570C2 (ru) 2010-04-14 2016-06-20 Алтрия Клаинт Сервисиз Инк. Отформованный бездымный табачный продукт
US9155321B2 (en) 2010-08-11 2015-10-13 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
US11116237B2 (en) * 2010-08-11 2021-09-14 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
AU2011338226B2 (en) 2010-12-10 2015-12-24 Altria Client Services Inc. Smokeless tobacco packaging system and method
CN112385883B (zh) * 2020-11-17 2022-11-04 云南中烟工业有限责任公司 一种用于电磁加热的加热不燃烧卷烟纸及其制备和用途

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2739600A (en) * 1955-07-01 1956-03-27 American Mach & Foundry Tobacco treatment
US4513756A (en) * 1983-04-28 1985-04-30 The Pinkerton Tobacco Company Process of making tobacco pellets
US4624269A (en) * 1984-09-17 1986-11-25 The Pinkerton Tobacco Company Chewable tobacco based product
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US6668839B2 (en) * 2001-05-01 2003-12-30 Jonnie R. Williams Smokeless tobacco product
US20040020503A1 (en) * 2001-05-01 2004-02-05 Williams Jonnie R. Smokeless tobacco product
US6834654B2 (en) * 2001-05-01 2004-12-28 Regent Court Technologies, Llc Smokeless tobacco product
US20050244521A1 (en) * 2003-11-07 2005-11-03 Strickland James A Tobacco compositions
US20060191548A1 (en) * 2003-11-07 2006-08-31 Strickland James A Tobacco compositions
US20080029116A1 (en) * 2006-08-01 2008-02-07 John Howard Robinson Smokeless tobacco
US20080029110A1 (en) * 2006-02-10 2008-02-07 R. J. Reynolds Tobacco Company Smokeless Tobacco Composition
US20080131508A1 (en) * 2006-12-01 2008-06-05 Cephalon, Inc Oral transmucosal nicotine dosage form
US20080209586A1 (en) * 2007-02-23 2008-08-28 U.S. Smokeless Tobacco Company Novel tobacco compositions and methods of making
US20090095313A1 (en) * 2007-10-11 2009-04-16 Fuisz Richard C Smokeless Tobacco Product, Smokeless Tobacco Product in the Form of a Sheet, Extrudable Tobacco Composition, Method for Manufacturing a Smokeless Tobacco Product, Method for Delivering Super Bioavailable Nicotine Contained in Tobacco to a User, and Packaged Smokeless Tobacco Product Sheet
US20090126746A1 (en) * 2006-01-31 2009-05-21 U.S. Smokless Tobacco Manufacturing Company, a CT corporation Tobacco Articles and Methods
US20090293889A1 (en) * 2007-11-28 2009-12-03 Philip Morris Usa Inc. Smokeless compressed tobacco product for oral consumption

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2142822B (en) * 1983-06-29 1987-02-11 Alec Stanley Walter Shaw Nicotine lozenges
US5372149A (en) * 1992-03-25 1994-12-13 Roth; David S. Sterilization process in the manufacturing of snuff
US7946296B2 (en) * 2006-05-26 2011-05-24 Philip Morris Usa Inc. Dissolvable tobacco film strips and method of making the same
JP5941609B2 (ja) * 2006-08-01 2016-06-29 アール・ジェイ・レノルズ・タバコ・カンパニーＲ．Ｊ．Ｒｅｙｎｏｌｄｓ Ｔｏｂａｃｃｏ Ｃｏｍｐａｎｙ 無煙たばこ
JP5193311B2 (ja) * 2007-12-21 2013-05-08 スウィーディッシュ・マッチ・ノース・ヨーロップ・アーベー 炭酸マグネシウムを含むタバコまたは非タバコ製品

Patent Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2739600A (en) * 1955-07-01 1956-03-27 American Mach & Foundry Tobacco treatment
US4513756A (en) * 1983-04-28 1985-04-30 The Pinkerton Tobacco Company Process of making tobacco pellets
US4624269A (en) * 1984-09-17 1986-11-25 The Pinkerton Tobacco Company Chewable tobacco based product
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US6668839B2 (en) * 2001-05-01 2003-12-30 Jonnie R. Williams Smokeless tobacco product
US20040020503A1 (en) * 2001-05-01 2004-02-05 Williams Jonnie R. Smokeless tobacco product
US6834654B2 (en) * 2001-05-01 2004-12-28 Regent Court Technologies, Llc Smokeless tobacco product
US20060191548A1 (en) * 2003-11-07 2006-08-31 Strickland James A Tobacco compositions
US20050244521A1 (en) * 2003-11-07 2005-11-03 Strickland James A Tobacco compositions
US20090133704A1 (en) * 2003-11-07 2009-05-28 Strickland James A Tobacco Compositions
US20090133703A1 (en) * 2003-11-07 2009-05-28 Strickland James A Tobacco compositions
US20090126746A1 (en) * 2006-01-31 2009-05-21 U.S. Smokless Tobacco Manufacturing Company, a CT corporation Tobacco Articles and Methods
US20080029110A1 (en) * 2006-02-10 2008-02-07 R. J. Reynolds Tobacco Company Smokeless Tobacco Composition
US7810507B2 (en) * 2006-02-10 2010-10-12 R. J. Reynolds Tobacco Company Smokeless tobacco composition
US20080029116A1 (en) * 2006-08-01 2008-02-07 John Howard Robinson Smokeless tobacco
US20080131508A1 (en) * 2006-12-01 2008-06-05 Cephalon, Inc Oral transmucosal nicotine dosage form
US20080209586A1 (en) * 2007-02-23 2008-08-28 U.S. Smokeless Tobacco Company Novel tobacco compositions and methods of making
US20090095313A1 (en) * 2007-10-11 2009-04-16 Fuisz Richard C Smokeless Tobacco Product, Smokeless Tobacco Product in the Form of a Sheet, Extrudable Tobacco Composition, Method for Manufacturing a Smokeless Tobacco Product, Method for Delivering Super Bioavailable Nicotine Contained in Tobacco to a User, and Packaged Smokeless Tobacco Product Sheet
US20090293889A1 (en) * 2007-11-28 2009-12-03 Philip Morris Usa Inc. Smokeless compressed tobacco product for oral consumption

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Kozlowski, Lynn, et al., "Filter ventilation and nicotine content of tobacco in cigarettes from Canada, the United Kingdom, and the United States", 1998, Tobacco Control 1998;7:369-375. *
Tobacco Reporter, "Smokeless Alternative", 12/09/2002. Legacy Tobacco Documents Library, University of California, San Franscico, Accesed via: http://legacy.library.ucsf.edu/tid/ece93g00 *

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD744160S1 (en) * 2005-10-18 2015-11-24 Swedish Match North Europe Ab Snuff box
USD738745S1 (en) * 2007-11-15 2015-09-15 Swedish Match North Europe Ab Snuff box with snuff bags
USD922674S1 (en) 2007-11-15 2021-06-15 Swedish Match North Europe Ab Configuration of snuff bags in a snuff box
USD860515S1 (en) 2007-11-15 2019-09-17 Swedish Match North Europe Ab Snuff bags in a snuff box
USD735054S1 (en) * 2007-11-15 2015-07-28 Swedish Match North Europe Ab Snuff box with snuff bags
USD913576S1 (en) 2007-11-15 2021-03-16 Swedish Match North Europe Ab Configuration of snuff bags in a snuff box
KR102316861B1 (ko) * 2010-12-01 2021-10-22 아아르. 제이. 레날드즈 토바코 캄파니 무연 담배 정제 및 무연 담배 제품을 성형하기 위한 성형 방법
KR20130121898A (ko) * 2010-12-01 2013-11-06 아아르. 제이. 레날드즈 토바코 캄파니 무연 담배 정제 및 무연 담배 제품을 성형하기 위한 성형 방법
JP2013544523A (ja) * 2010-12-01 2013-12-19 アール・ジエイ・レイノルズ・タバコ・カンパニー 無煙タバコ香錠および無煙タバコ製品を形成する方法
CN103458714A (zh) * 2010-12-01 2013-12-18 R·J·雷诺兹烟草公司 无烟烟草锭剂和用于形成无烟烟草产品的模铸方法
WO2012075035A3 (en) * 2010-12-01 2012-07-26 R. J. Reynolds Tobacco Company Smokeless tobacco pastille and moulding process for forming smokeless tobacco products
US9204667B2 (en) 2010-12-01 2015-12-08 R.J. Reynolds Tobacco Company Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products
WO2012074865A1 (en) * 2010-12-01 2012-06-07 R. J. Reynolds Tobacco Company Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products
US9775376B2 (en) 2010-12-01 2017-10-03 R.J. Reynolds Tobacco Company Smokeless tobacco pastille and moulding process for forming smokeless tobacco products
KR20190107193A (ko) * 2010-12-01 2019-09-18 아아르. 제이. 레날드즈 토바코 캄파니 무연 담배 정제 및 무연 담배 제품을 성형하기 위한 성형 방법
US9370204B2 (en) * 2011-03-30 2016-06-21 Japan Tobacco Inc. Oral tobacco and method for manufacturing the same
US20140020692A1 (en) * 2011-03-30 2014-01-23 Japan Tobacco Inc. Oral tobacco and method for manufacturing the same
US20130340776A1 (en) * 2012-06-20 2013-12-26 Munmaya K. Mishra Smokeless Tobacco Lipid Granules
US11944114B2 (en) * 2012-06-20 2024-04-02 Altria Client Services Llc Smokeless tobacco lipid granules
US20190246685A1 (en) * 2013-03-14 2019-08-15 Altria Client Services Llc Smokeless tobacco article
US10881130B2 (en) * 2013-03-14 2021-01-05 Altria Client Services Llc Smokeless tobacco article
US11737485B2 (en) 2013-03-14 2023-08-29 Altria Client Services Llc Smokeless tobacco article
US20150096574A1 (en) * 2013-10-03 2015-04-09 Altria Client Services Inc. Dissolvable-chewable tobacco tablet
US20200054064A1 (en) * 2017-05-24 2020-02-20 Philip Morris Products S.A. Heated aerosol-generating article comprising homogenised botanical material

Also Published As

Publication number Publication date
MX2011003882A (es) 2011-05-19
MY159762A (en) 2017-01-31
EP2381803A1 (en) 2011-11-02
WO2010086010A1 (en) 2010-08-05
PL2381803T3 (pl) 2014-11-28
BRPI0924206A2 (pt) 2016-01-19
DK2381803T3 (da) 2014-07-14
EP2213181A1 (en) 2010-08-04
JP2012516137A (ja) 2012-07-19
KR101779615B1 (ko) 2017-10-10
TW201036559A (en) 2010-10-16
ECSP11011291A (es) 2011-09-30
TWI513413B (zh) 2015-12-21
RU2011115844A (ru) 2013-03-10
EP2381803B1 (en) 2014-06-04
KR20110110762A (ko) 2011-10-07
UA100473C2 (uk) 2012-12-25
CA2737323C (en) 2016-06-21
CA2737323A1 (en) 2010-08-05

Similar Documents

Publication Publication Date Title
CA2737323C (en) Smokeless dissolvable compressed tobacco product
US11737485B2 (en) Smokeless tobacco article
US11445744B2 (en) Tobacco beads
US12083110B2 (en) Nicotine lozenge
US20230397647A1 (en) Chewable dissolvable nicotine tablet
US11612183B2 (en) Protein-enriched tobacco composition
EP2613653B1 (en) Smokeless tobacco product comprising effervescent composition
US9155772B2 (en) Soft, chewable and orally dissolvable and/or disintegrable products
US20150096575A1 (en) Tobacco lozenge
US20150096574A1 (en) Dissolvable-chewable tobacco tablet
EP3052081B1 (en) Lozenge
WO2015051306A1 (en) Dissolvable chewable tablet

Legal Events

Date Code Title Description
AS Assignment

Owner name: PHILIP MORRIS USA INC., VIRGINIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIVEHED, HAKAN;REEL/FRAME:024705/0336

Effective date: 20100309

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION